These results suggested that in cervical tumors and head and neck tumors with PIK3CA alterations, the pro-tumor function of FSCN1 may be mediated by 14-3-3ζ, which modulates signal transduction by binding to phosphoserine-containing proteins (Figure 5). This evidence concerns the gene FSCN1 and neoplasm.